HOST SUPPORTED GENETIC BIOSENSORS
    5.
    发明申请
    HOST SUPPORTED GENETIC BIOSENSORS 审中-公开
    主机支持的遗传生物传感器

    公开(公告)号:US20120076736A1

    公开(公告)日:2012-03-29

    申请号:US13234992

    申请日:2011-09-16

    CPC classification number: G01N33/542 C07K2319/00 C07K2319/20 G01N33/66

    Abstract: The present invention relates to an in vivo method of monitoring an analyte in a subject. This method involves providing an expression vector that encodes a biosensor molecule, the biosensor molecule comprising an analyte binding domain and a signal domain. The biosensor molecule produces a signal from the signal domain upon binding of the analyte by the analyte binding domain. The signal is detectable by a non-invasive means. The expression vector is introduced locally into in vivo cells of a subject under conditions effective to express the biosensor molecule in the cells. The signal from the expressed biosensor molecule is detected by a non-invasive means, thereby monitoring the analyte in the subject in vivo.

    Abstract translation: 本发明涉及一种监测受试者中分析物的体内方法。 该方法包括提供编码生物传感器分子的表达载体,生物传感器分子包含分析物结合域和信号结构域。 当分析物结合分析物结合域时,生物传感器分子从信号域产生信号。 该信号可通过非侵入性手段检测。 在有效表达细胞内的生物传感器分子的条件下,将表达载体局部引入受试者的体内细胞。 通过非侵入性手段检测来自表达的生物传感器分子的信号,从而在体内监测受试者中的分析物。

    Noninvasive Diagnostics of Proximal Heart Health Biomarkers

    公开(公告)号:US20210219924A1

    公开(公告)日:2021-07-22

    申请号:US17150920

    申请日:2021-01-15

    Abstract: An integrated bioinstrumentation system, combining an accurate and robust quasi 1D computational model with experimental peripheral measurements, is designed to extract information on other quantities of interest, for which the direct measurements are not feasible. The system is able to quantify and visualize the distributions of a cardiac output (CO), aortic blood pressure (BP), flow, velocity, and aortic arterial compliance, based on a peripheral analysis of a pulse transit time (PTT) measured at the available peripheral sites. A preliminary calibration stage extracts the arterial properties from simultaneous measurements of a pulse transit time, and an upper arm blood pressure. Obtained transfer functions, linking noninvasive peripheral measurements to the aortic pressure, cardiac output, aortic compliance and others serve to quantify the indicators of cardiac morbidity and mortality.

Patent Agency Ranking